“New technologies that are approved by the FDA but not reimbursed by CMS face a classic ‘Catch 22’,” said Mark Carol, MD, chair of MITA’s Focused Ultrasound Section.

A representative from the Medical Imaging & Technology Alliance (MITA) spoke at a public hearing organized by the Department of Health and Human Services, sharing insight into how patients can gain better access to key technologies.

DenseBreast-info, Inc. (DB-I) has shared its public comments on the FDA’s proposed changes to the Mammography Quality Standards Act of 1992 (MQSA). The FDA first announced its efforts to amend the MQSA back in March.

Canon Medical Systems USA has received FDA approval for its deep convolutional neural network (DCNN) image reconstruction technology for CT scanning.

President Trump is promising a new healthcare plan for the nation in recent media interviews, though there have been scant details so far.

The pharmaceutical industry is taking action after the Trump administration finalized a rule that would require drugmakers to publish list prices in television ads.

The Trump administration was warned that its policy changes undermining the Affordable Care Act would cause disruption to healthcare coverage and likely increase taxes, according to a leaked internal memo, first reported by Politico. CMS Administrator Seema Verma penned the memo in August 2018 and outlined how several policy changes could negatively impact the ACA market.

As Medicare for all continues to gain traction among American voters and more Democratic presidential nominees take up the platform, the American Medical Association has decided not to support such an initiative.